Application of microRNA in diagnosis and treatment of ovarian cancer
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug‐resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug‐resistant. The morbidity and mortality of ovarian cancer are …
[PDF][PDF] Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
K Banno, M Yanokura, M Iida, M Adachi, K Nakamura… - 2014 - researchgate.net
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
Application of microRNA in diagnosis and treatment of ovarian cancer.
K Banno, M Yanokura, M Iida, M Adachi… - Biomed Research …, 2014 - europepmc.org
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
K Banno, M Yanokura, M Iida, M Adachi… - BioMed Research …, 2014 - search.proquest.com
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
K Banno, M Yanokura, M Iida, M Adachi… - BioMed Research …, 2014 - cir.nii.ac.jp
抄録< jats: p> Ovarian cancer has a poor prognosis because early detection is difficult and
recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian …
recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian …
Application of microRNA in diagnosis and treatment of ovarian cancer
K Banno, M Yanokura, M Iida… - BioMed research …, 2014 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
[PDF][PDF] Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
K Banno, M Yanokura, M Iida, M Adachi, K Nakamura… - academia.edu
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
Application of MicroRNA in diagnosis and treatment of ovarian cancer
K Banno, M Yanokura, M Iida, M Adachi… - BioMed Research …, 2014 - pure.fujita-hu.ac.jp
抄録 Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
Application of MicroRNA in diagnosis and treatment of ovarian cancer
K Banno, M Yanokura, M Iida… - BioMed Research …, 2014 - keio.elsevierpure.com
抄録 Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
[PDF][PDF] Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
K Banno, M Yanokura, M Iida, M Adachi, K Nakamura… - 2014 - cyberleninka.org
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …
ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are …